Literature DB >> 1349451

Colocalization of prion protein and beta protein in the same amyloid plaques in patients with Gerstmann-Sträussler syndrome.

M Miyazono1, T Kitamoto, T Iwaki, J Tateishi.   

Abstract

We examined paraffin-embedded brain sections from three patients with Creutzfeldt-Jakob disease (CJD) and four patients with Gerstmann-Sträussler syndrome (GSS) who also had beta protein deposits in the brains. Immunostaining using anti-prion protein (PrP) and anti-beta protein coupled with formic acid pretreatment, revealed PrP deposits and beta protein deposits, respectively. In all four GSS patients examined, sequential double immunostaining and single immunostaining in serial sections or simultaneous double immunofluorescence revealed the colocalization of PrP and beta protein in the same amyloid plaques. The plaques labeled with both antibodies were designated as beta-PrP plaques. Small kuru plaques of less than 15 microns in diameter were rarely found to coexist with beta deposits. The percentages of beta-PrP plaques in larger kuru plaques were not constant among the four GSS patients. The colocalization patterns of both deposits were observed as being roughly of two types as follows: (1) diffuse beta protein deposits located around the PrP core; and (2) a beta protein core and PrP core simultaneously existing in one amyloid plaque. Under an electron microscope, we were able to confirm the presence of both beta protein and PrP in a single plaque in four GSS patients older than 60 years old. In contrast, no colocalization of either deposits was seen in the amyloid plaque core fractions of a young GSS patient who had no beta protein deposits, even at the electron microscopic level. Therefore, the colocalization of both proteins in a single plaque is believed to be age-related and incidental in GSS patients but suggests a similar morphogenesis of both amyloid deposits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349451     DOI: 10.1007/bf00713522

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Coexistence of Creutzfeldt-Jakob disease and Alzheimer's disease in the same patient.

Authors:  P Brown; F Jannotta; C J Gibbs; H Baron; D C Guiroy; D C Gajdusek
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

2.  Pro----leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome.

Authors:  K Doh-ura; J Tateishi; H Sasaki; T Kitamoto; Y Sakaki
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

3.  [Association of Alzheimer's disease and Creutzfeldt-Jakob's disease (author's transl)].

Authors:  J Gaches; V Supino-Viterbo; J F Foncin
Journal:  Acta Neurol Belg       Date:  1977 Jul-Aug       Impact factor: 2.396

4.  CNS amyloid proteins in neurodegenerative diseases.

Authors:  G W Roberts; R Lofthouse; D Allsop; M Landon; M Kidd; S B Prusiner; T J Crow
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

5.  Immuno-gold localization of prion filaments in scrapie-infected hamster brains.

Authors:  C A Wiley; P G Burrola; M J Buchmeier; M K Wooddell; R A Barry; S B Prusiner; P W Lampert
Journal:  Lab Invest       Date:  1987-12       Impact factor: 5.662

6.  A cellular gene encodes scrapie PrP 27-30 protein.

Authors:  B Oesch; D Westaway; M Wälchli; M P McKinley; S B Kent; R Aebersold; R A Barry; P Tempst; D B Teplow; L E Hood
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

7.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

8.  Gerstmann-Sträussler-Scheinker disease: immunohistological and experimental studies.

Authors:  J Tateishi; T Kitamoto; H Hashiguchi; H Shii
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

9.  Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Sträussler syndrome.

Authors:  K Doh-ura; J Tateishi; T Kitamoto; H Sasaki; Y Sakaki
Journal:  Ann Neurol       Date:  1990-02       Impact factor: 10.422

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  23 in total

1.  Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Authors:  Fumiko Furukawa; Nobuo Sanjo; Atsushi Kobayashi; Tsuyoshi Hamaguchi; Masahito Yamada; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Takanori Yokota
Journal:  Prion       Date:  2018-11-13       Impact factor: 3.931

2.  Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

Review 3.  Cross currents in protein misfolding disorders: interactions and therapy.

Authors:  Rodrigo Morales; Kristi M Green; Claudio Soto
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

4.  [(11)C]PiB PET in Gerstmann-Sträussler-Scheinker disease.

Authors:  Kacie D Deters; Shannon L Risacher; Karmen K Yoder; Adrian L Oblak; Frederick W Unverzagt; Jill R Murrell; Francine Epperson; Eileen F Tallman; Kimberly A Quaid; Martin R Farlow; Andrew J Saykin; Bernardino Ghetti
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-01-28

5.  Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.

Authors:  M Preusser; T Ströbel; E Gelpi; M Eiler; G Broessner; E Schmutzhard; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

6.  Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils.

Authors:  Jingmin Yan; Xiaoying Fu; Fengxia Ge; Beiru Zhang; Junjie Yao; Huanyu Zhang; Jinze Qian; Hiroshi Tomozawa; Hironobu Naiki; Jinko Sawashita; Masayuki Mori; Keiichi Higuchi
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

7.  Creutzfeldt-Jakob disease and cerebral amyloid angiopathy.

Authors:  F Gray; F Chrétien; P Cesaro; J Chatelain; P Beaudry; J L Laplanche; J Mikol; J Bell; P Gambetti; J D Degos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.

Authors:  Nupur Ghoshal; Ignazio Cali; Richard Justin Perrin; S Andrew Josephson; Ning Sun; Pierluigi Gambetti; John Carl Morris
Journal:  Arch Neurol       Date:  2009-10

9.  Gerstmann-Sträussler-Scheinker disease showing beta-protein type cerebellar and cerebral amyloid angiopathy.

Authors:  S I Ikeda; N Yanagisawa; D Allsop; G G Glenner
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 10.  The amyloid state of proteins in human diseases.

Authors:  David Eisenberg; Mathias Jucker
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.